Product Information

DOXYCYCLINE MONO 150 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.5635 per EA under NDC 64380020801. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Dec 15, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXYCYCLINE MONO 150 MG TABLET

doxycycline
$0.5635per EA

Strength

150 mg/1

NDC

64380020801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXYCYCLINE

Approval Type

Generic (ANDA)

FDA Application

ANDA065070

FDA Approved

12/15/2000

TE Code

AB

On Market Since

9/19/2022

Pharmacological Classes

Price Statistics

The NADAC for DOXYCYCLINE MONO 150 MG TABLET has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 49.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5635 per EA
All-time high$1.2023 (May 14, 2025)
All-time low$0.5635 (Nov 18, 2026)
52-week high$0.9656
52-week low$0.5635
Median price$0.9395
Average price$0.8965
Largest weekly change-19.0% (May 21, 2025)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

-6.3%

1M

-11.1%

3M

-12.6%

6M

-23.9%

1Y

-43.9%

3Y

N/A

5Y

N/A

All

-49.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxycycline market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXYCYCLINE MONO 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 150 MG TABLET, manufactured by Strides Pharma Inc., is $0.5635 per EA (NDC 64380020801), effective Nov 18, 2026.

How has the price of DOXYCYCLINE MONO 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has declined 49.9%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 150 MG TABLET?

Since Apr 17, 2024, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has ranged from a low of $0.5635 (Nov 18, 2026) to a high of $1.2023 (May 14, 2025), with a median of $0.9395 per EA.

Are there cheaper alternatives to DOXYCYCLINE MONO 150 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of DOXYCYCLINE MONO 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DOXYCYCLINE MONO 150 MG TABLET?

DOXYCYCLINE MONO 150 MG TABLET (NDC 64380020801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.